Dr. Rosalind Watts

Researching Psilocybin's Effects on Depression - Dr. Rosalind Watts

Dr. Rosalind Watts, Craig Cannon

Led by Professors Robin Carhart-Harris and David Nutt, a pioneering research initiative successfully demonstrated that high-dose psilocybin can deactivate brain regions linked to negative rumination and offer a "reset" for patients with severe, treatment-resistant depression. Although the study achieved a 100% preference rate for psilocybin over prior treatments among its 20 participants, long-term efficacy remains limited by the absence of formal integration therapy, prompting calls for structured follow-up sessions to sustain behavioral changes. Currently constrained by reliance on single-source funding, the researchers are prioritizing comparative trials against antidepressants while advocating for a holistic therapeutic model that combines preparation, ego-dissolving experiences, and sustained support to address the growing crisis of ineffective psychiatric medication.